Table 5. Estimated Clearance, Rate Constants ke, k12, and k21, Elimination Half-life (T1/2γz) and Initial Volume of Distribution (V1) in Patients Phenotypically Homozygous for the Atypical Plasma Cholinesterase Enzyme before and after Administration of Human Plasma Cholinesterase